Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

SABSSABS
4 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in SAB BIOTHERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 191,305 shares of SABS (SAB BIOTHERAPEUTICS INC), worth $746,089 as of 2026-Q2. The position was increased (+67.9% shares). SABS represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$746,089

Current Shares

191,305

Total Value Change

+$723,535

Total Shares Change

+180,084

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
191,305
+67.9%
$746,0890.0%$3.90
36
2026-Q1
Increased
113,940
+121.9%
$436,3900.0%$3.89
39
2025-Q4
Increased
51,348
+357.6%
$192,0420.0%$3.77
25
2025-Q3
New
11,221
-
$22,5540.0%$1.95
29

Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used